Neuphoria Therapeutics
$3.05
15
-$0.01-0.33%Friday 20:00
-$0.02-0.66%Friday 20:23After hours
Statistics
Day High
3.06
Day Low
3.06
52W High
5.53
52W Low
3.03
Volume
267
Avg. Volume
-
Mkt Cap
16.5M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-4.41
-3.1
-1.78
-0.47
Expected EPS
-1.58
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NEUP. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company focused on therapies for serious central nervous system disorders. Its lead product candidate, BNC210, is an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic acetylcholine receptor. The company has discontinued development of BNC210 for social anxiety disorder, while its BNC210 program for post-traumatic stress disorder is currently paused and no active clinical trial is underway. The company operates through a single operating and reporting segment focused on the discovery and development of allosteric ion-channel modulators for serious CNS disorders with high unmet medical need.
Show More
CEO
Spyridon Papapetropoulos
Employees
1
Country
United States
ISIN
US64136E1029
Listings
0 Comments
Share your thoughts
FAQs
What is Neuphoria Therapeutics stock price today?▼
The current price of NEUP is $3.05 USD — it has decreased by -0.33% in the past 24 hours. Watch Neuphoria Therapeutics stock price performance more closely on the chart.
What is Neuphoria Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Neuphoria Therapeutics stocks are traded under the ticker NEUP.
Is Neuphoria Therapeutics stock price growing?▼
NEUP stock has fallen by -9.76% compared to the previous week, the month change is a -12.1% fall, over the last year Neuphoria Therapeutics has showed a -32.97% decrease.
What is Neuphoria Therapeutics market cap?▼
Today Neuphoria Therapeutics has the market capitalization of 16.5M
When is the next Neuphoria Therapeutics earnings date?▼
Neuphoria Therapeutics is going to release the next earnings report on December 2, 2026.
What were Neuphoria Therapeutics earnings last quarter?▼
NEUP earnings for the last quarter are -0.56 USD per share, whereas the estimation was -0.56 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Neuphoria Therapeutics have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is Neuphoria Therapeutics located?▼
Neuphoria Therapeutics operates in the Health & Wellness sector.
When did Neuphoria Therapeutics complete a stock split?▼
Neuphoria Therapeutics has not had any recent stock splits.
Where is Neuphoria Therapeutics headquartered?▼
Neuphoria Therapeutics is headquartered in BURLINGTON, United States.